Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Cell adhesion molecules are important in the development of certain skin diseases.

EGFR is crucial for preventing hair follicle inflammation and hair loss.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

L. plantarum MTCC 1325 may help improve memory and cognitive functions in Alzheimer's.

Hair follicles produce IL-7, which is essential for certain skin lymphoma cells to survive.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Microneedles can precisely deliver cancer treatments with fewer side effects.

Neoplasms hide in hair follicles to avoid the immune system.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Restoring hair follicle immune privilege may help treat alopecia areata.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Gentamicin-loaded exosomes improve healing of infected diabetic wounds in mice.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Macrophages help maintain mammary stem cells and balance through specific signaling.

Human prenatal skin develops an immune network early on that helps with skin formation and healing without scarring.

Immortalized hair follicle cells could be useful for regenerative medicine and treating inflammation and oxidative stress.